Outlook Therapeutics OTLK Q1 2026 Results Miss Estimates EPS 016 vs 012 Accelerant ARX Jumps 650 on Strong Momentum 20260515 Mirion Technologies MIR Drops 235 Key Support at 1756 20260515 Reed Jobs Yosemite Fund Eyes UK Cancer Care Investments Continuing Fathers Legacy PennantPark Investment Corporation PNNT Gains 26 as Stock Nears Key Resistance Level MACOM Technology Solutions MTSI Shares Decline 258 as Tech Sector Headwinds Persist Columbus Circle Capital Corp II Warrants CMIIW Remain Flat at 034 as Investors Await Catalyst Autolus Therapeutics AUTL Gains 268 as Stock Nears Key Resistance Level